Annual report pursuant to section 13 and 15(d)

Consolidated Statement of Shareholders Equity (Deficit)

v2.4.0.6
Consolidated Statement of Shareholders Equity (Deficit) (USD $)
Common Stock
Additional Paid-In Capital
Retained Earnings / Accumulated Deficit
Noncontrolling Interest
Total
Beginning balance, value at Apr. 29, 2011               
Beginning balance, shares at Apr. 29, 2011           
Common stock issued to officers for cash, shares 10,000,000        
Common stock issued to officers for cash, value 1,000 4,000     5,000
Common stock issued for advance payable, value           
Common stock issued pursuant to an option agreement, value           
Common stock issued for acquisition of patents, value           
Proceeds from disgorgement of former officer short swing profits           
Net loss     (109,322)   (109,322)
Ending balance, value at Dec. 31, 2011 1,000 4,000 (109,322)   (104,322)
Ending balance, shares at Dec. 31, 2011 10,000,000        
Recapitalization of the Company, shares 7,500,000        
Recapitalization of the Company, value 750 2,650     3,400
Common stock issued for cash, shares 13,449,965        
Common stock issued for cash, value 1,345 6,510,620     6,511,965
Common stock issued for advance payable, shares 200,000        
Common stock issued for advance payable, value 20 99,980     100,000
Common stock issued for legal services, shares 375,000        
Common stock issued for legal services, value 38 164,962     165,000
Common stock issued pursuant to an option agreement, shares 10,000,000        
Common stock issued pursuant to an option agreement, value 1,000       1,000
Common stock issued for compensation, shares 83,218        
Common stock issued for compensation, value 9 33,278     33,287
Common stock issued for exercise of warrants on a cashless basis, shares 4,494,829        
Common stock issued for exercise of warrants on a cashless basis, value 449 (449)       
Common stock issued for acquisition of patents, shares 9,250,000        
Common stock issued for acquisition of patents, value 925       925
Stock-based compensation in connection with warrants granted to employees and consultants, value   4,238,100     4,238,100
Cancellation of common stock in connection with rescission agreement, shares (9,806,667)        
Cancellation of common stock in connection with rescission agreement, value (981) (131,019)     (132,000)
Proceeds from disgorgement of former officer short swing profits   50,000     50,000
Net loss     (6,927,812) (10,496) (6,938,308)
Ending balance, value at Dec. 31, 2012 $ 4,555 $ 10,972,122 $ (7,037,134) $ (10,496) $ 3,929,047
Ending balance, shares at Dec. 31, 2012 45,546,345